학술논문

Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive–compulsive disorder: a systematic review and meta-analysis of randomized clinical trials
Document Type
Article
Source
In: Scientific Reports. (Scientific Reports, December 2023, 13(1))
Subject
Language
English
ISSN
20452322